TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Next Generation Cancer Diagnostic Devices Market Report & Forecast 2022-2028

Global and United States Next Generation Cancer Diagnostic Devices Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 12 September 2022
  • Pages :110
  • Formats:
  • Report Code:SMR-7346220
OfferClick for best price

Best Price: $3480

Next Generation Cancer Diagnostic Devices Market Size, Share 2022


Market Analysis and Insights: Global Next Generation Cancer Diagnostic Devices Market

The global Next Generation Cancer Diagnostic Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Cancer Diagnostic Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Cancer Diagnostic Devices market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Cancer Diagnostic Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Cancer Diagnostic Devices market.

Global Next Generation Cancer Diagnostic Devices Scope and Market Size

Next Generation Cancer Diagnostic Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Next Generation Cancer Diagnostic Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Next Generation Sequencing

qPCR & Multiplexing

Lab-on- a- chip (LOAC)

Protein Microarrays

DNA Microarrays

Reverse Transcriptase-PCR (RT-PCR)

Segment by Application

Biomarker Development

CTC Analysis

Proteomic Analysis

Epigenetic Analysis

Genetic Analysis

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Roche Holding Ltd.?Switzerland)

Abbott Laboratories(US)

Siemens Healthcare(Germany)

Agilent Technologies Inc(Germany)

Illumina Inc.(US)

Becton Dickinson and Co.(US)

QIAGEN N.V.(Germany)

Affymetrix Inc.(US)

Johnson & Johnson(US)

Thermo Fisher Scientific Inc.(US)

GE Healthcare(England)

Life Technologies Corp.(US)

Luminex Corp.(US)

Cepheid Inc.(US)

Allegro Diagnostics Corp.(Brazil)

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Next Generation Cancer Diagnostic Devices product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Next Generation Cancer Diagnostic Devices, with price, sales, revenue, and global market share of Next Generation Cancer Diagnostic Devices from 2019 to 2022.

Chapter 3, the Next Generation Cancer Diagnostic Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Next Generation Cancer Diagnostic Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Next Generation Cancer Diagnostic Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Next Generation Cancer Diagnostic Devices.

Chapter 13, 14, and 15, to describe Next Generation Cancer Diagnostic Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Next Generation Cancer Diagnostic Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Next Generation Cancer Diagnostic Devices Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 110 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Global Next Generation Cancer Diagnostic Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume for the Year 2017-2028
1.3 United States Next Generation Cancer Diagnostic Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Next Generation Cancer Diagnostic Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume for the Year 2017-2028
1.4 Next Generation Cancer Diagnostic Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Next Generation Cancer Diagnostic Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Next Generation Cancer Diagnostic Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Next Generation Cancer Diagnostic Devices Market Dynamics
1.5.1 Next Generation Cancer Diagnostic Devices Industry Trends
1.5.2 Next Generation Cancer Diagnostic Devices Market Drivers
1.5.3 Next Generation Cancer Diagnostic Devices Market Challenges
1.5.4 Next Generation Cancer Diagnostic Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Next Generation Cancer Diagnostic Devices Market Segment by Type
2.1.1 Next Generation Sequencing
2.1.2 qPCR & Multiplexing
2.1.3 Lab-on- a- chip (LOAC)
2.1.4 Protein Microarrays
2.1.5 DNA Microarrays
2.1.6 Reverse Transcriptase-PCR (RT-PCR)
2.2 Global Next Generation Cancer Diagnostic Devices Market Size by Type
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Next Generation Cancer Diagnostic Devices Market Size by Type
2.3.1 United States Next Generation Cancer Diagnostic Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Next Generation Cancer Diagnostic Devices Market Segment by Application
3.1.1 Biomarker Development
3.1.2 CTC Analysis
3.1.3 Proteomic Analysis
3.1.4 Epigenetic Analysis
3.1.5 Genetic Analysis
3.2 Global Next Generation Cancer Diagnostic Devices Market Size by Application
3.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Next Generation Cancer Diagnostic Devices Market Size by Application
3.3.1 United States Next Generation Cancer Diagnostic Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Next Generation Cancer Diagnostic Devices Competitor Landscape by Company
4.1 Global Next Generation Cancer Diagnostic Devices Market Size by Company
4.1.1 Top Global Next Generation Cancer Diagnostic Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Next Generation Cancer Diagnostic Devices Price by Manufacturer (2017-2022)
4.2 Global Next Generation Cancer Diagnostic Devices Concentration Ratio (CR)
4.2.1 Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Next Generation Cancer Diagnostic Devices in 2021
4.2.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Next Generation Cancer Diagnostic Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
4.3.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Next Generation Cancer Diagnostic Devices Market Size by Company
4.5.1 Top Next Generation Cancer Diagnostic Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Next Generation Cancer Diagnostic Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Next Generation Cancer Diagnostic Devices Sales by Players (2020, 2021 & 2022)
5 Global Next Generation Cancer Diagnostic Devices Market Size by Region
5.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Next Generation Cancer Diagnostic Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Next Generation Cancer Diagnostic Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Next Generation Cancer Diagnostic Devices Sales in Value by Region: 2017-2022
5.3.2 Global Next Generation Cancer Diagnostic Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.1.2 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Roche Holding Ltd.?Switzerland)
7.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
7.1.2 Roche Holding Ltd.?Switzerland) Description and Business Overview
7.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
7.1.5 Roche Holding Ltd.?Switzerland) Recent Development
7.2 Abbott Laboratories(US)
7.2.1 Abbott Laboratories(US) Corporation Information
7.2.2 Abbott Laboratories(US) Description and Business Overview
7.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
7.2.5 Abbott Laboratories(US) Recent Development
7.3 Siemens Healthcare(Germany)
7.3.1 Siemens Healthcare(Germany) Corporation Information
7.3.2 Siemens Healthcare(Germany) Description and Business Overview
7.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.3.5 Siemens Healthcare(Germany) Recent Development
7.4 Agilent Technologies Inc(Germany)
7.4.1 Agilent Technologies Inc(Germany) Corporation Information
7.4.2 Agilent Technologies Inc(Germany) Description and Business Overview
7.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.4.5 Agilent Technologies Inc(Germany) Recent Development
7.5 Illumina Inc.(US)
7.5.1 Illumina Inc.(US) Corporation Information
7.5.2 Illumina Inc.(US) Description and Business Overview
7.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.5.5 Illumina Inc.(US) Recent Development
7.6 Becton Dickinson and Co.(US)
7.6.1 Becton Dickinson and Co.(US) Corporation Information
7.6.2 Becton Dickinson and Co.(US) Description and Business Overview
7.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.6.5 Becton Dickinson and Co.(US) Recent Development
7.7 QIAGEN N.V.(Germany)
7.7.1 QIAGEN N.V.(Germany) Corporation Information
7.7.2 QIAGEN N.V.(Germany) Description and Business Overview
7.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.7.5 QIAGEN N.V.(Germany) Recent Development
7.8 Affymetrix Inc.(US)
7.8.1 Affymetrix Inc.(US) Corporation Information
7.8.2 Affymetrix Inc.(US) Description and Business Overview
7.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.8.5 Affymetrix Inc.(US) Recent Development
7.9 Johnson & Johnson(US)
7.9.1 Johnson & Johnson(US) Corporation Information
7.9.2 Johnson & Johnson(US) Description and Business Overview
7.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
7.9.5 Johnson & Johnson(US) Recent Development
7.10 Thermo Fisher Scientific Inc.(US)
7.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
7.10.2 Thermo Fisher Scientific Inc.(US) Description and Business Overview
7.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
7.11 GE Healthcare(England)
7.11.1 GE Healthcare(England) Corporation Information
7.11.2 GE Healthcare(England) Description and Business Overview
7.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Products Offered
7.11.5 GE Healthcare(England) Recent Development
7.12 Life Technologies Corp.(US)
7.12.1 Life Technologies Corp.(US) Corporation Information
7.12.2 Life Technologies Corp.(US) Description and Business Overview
7.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Life Technologies Corp.(US) Products Offered
7.12.5 Life Technologies Corp.(US) Recent Development
7.13 Luminex Corp.(US)
7.13.1 Luminex Corp.(US) Corporation Information
7.13.2 Luminex Corp.(US) Description and Business Overview
7.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Luminex Corp.(US) Products Offered
7.13.5 Luminex Corp.(US) Recent Development
7.14 Cepheid Inc.(US)
7.14.1 Cepheid Inc.(US) Corporation Information
7.14.2 Cepheid Inc.(US) Description and Business Overview
7.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Cepheid Inc.(US) Products Offered
7.14.5 Cepheid Inc.(US) Recent Development
7.15 Allegro Diagnostics Corp.(Brazil)
7.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
7.15.2 Allegro Diagnostics Corp.(Brazil) Description and Business Overview
7.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Allegro Diagnostics Corp.(Brazil) Products Offered
7.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Next Generation Cancer Diagnostic Devices Industry Chain Analysis
8.2 Next Generation Cancer Diagnostic Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Next Generation Cancer Diagnostic Devices Distributors
8.3 Next Generation Cancer Diagnostic Devices Production Mode & Process
8.4 Next Generation Cancer Diagnostic Devices Sales and Marketing
8.4.1 Next Generation Cancer Diagnostic Devices Sales Channels
8.4.2 Next Generation Cancer Diagnostic Devices Distributors
8.5 Next Generation Cancer Diagnostic Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Next Generation Cancer Diagnostic Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Next Generation Cancer Diagnostic Devices Market Trends
Table 3. Next Generation Cancer Diagnostic Devices Market Drivers
Table 4. Next Generation Cancer Diagnostic Devices Market Challenges
Table 5. Next Generation Cancer Diagnostic Devices Market Restraints
Table 6. Global Next Generation Cancer Diagnostic Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Next Generation Cancer Diagnostic Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Next Generation Cancer Diagnostic Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Next Generation Cancer Diagnostic Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Next Generation Cancer Diagnostic Devices Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturer, 2017-2022
Table 13. Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Next Generation Cancer Diagnostic Devices Sales Share by Manufacturer, 2017-2022
Table 15. Global Next Generation Cancer Diagnostic Devices Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Next Generation Cancer Diagnostic Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2021)
Table 18. Top Players of Next Generation Cancer Diagnostic Devices in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 20. Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Next Generation Cancer Diagnostic Devices Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Next Generation Cancer Diagnostic Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Next Generation Cancer Diagnostic Devices Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Next Generation Cancer Diagnostic Devices Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Next Generation Cancer Diagnostic Devices Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Next Generation Cancer Diagnostic Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Next Generation Cancer Diagnostic Devices Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Next Generation Cancer Diagnostic Devices Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Next Generation Cancer Diagnostic Devices Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Next Generation Cancer Diagnostic Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Next Generation Cancer Diagnostic Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Next Generation Cancer Diagnostic Devices Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Next Generation Cancer Diagnostic Devices Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Next Generation Cancer Diagnostic Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Next Generation Cancer Diagnostic Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Next Generation Cancer Diagnostic Devices Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Roche Holding Ltd.?Switzerland) Corporation Information
Table 43. Roche Holding Ltd.?Switzerland) Description and Business Overview
Table 44. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 46. Roche Holding Ltd.?Switzerland) Recent Development
Table 47. Abbott Laboratories(US) Corporation Information
Table 48. Abbott Laboratories(US) Description and Business Overview
Table 49. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Abbott Laboratories(US) Product
Table 51. Abbott Laboratories(US) Recent Development
Table 52. Siemens Healthcare(Germany) Corporation Information
Table 53. Siemens Healthcare(Germany) Description and Business Overview
Table 54. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Siemens Healthcare(Germany) Product
Table 56. Siemens Healthcare(Germany) Recent Development
Table 57. Agilent Technologies Inc(Germany) Corporation Information
Table 58. Agilent Technologies Inc(Germany) Description and Business Overview
Table 59. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Agilent Technologies Inc(Germany) Product
Table 61. Agilent Technologies Inc(Germany) Recent Development
Table 62. Illumina Inc.(US) Corporation Information
Table 63. Illumina Inc.(US) Description and Business Overview
Table 64. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Illumina Inc.(US) Product
Table 66. Illumina Inc.(US) Recent Development
Table 67. Becton Dickinson and Co.(US) Corporation Information
Table 68. Becton Dickinson and Co.(US) Description and Business Overview
Table 69. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Becton Dickinson and Co.(US) Product
Table 71. Becton Dickinson and Co.(US) Recent Development
Table 72. QIAGEN N.V.(Germany) Corporation Information
Table 73. QIAGEN N.V.(Germany) Description and Business Overview
Table 74. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. QIAGEN N.V.(Germany) Product
Table 76. QIAGEN N.V.(Germany) Recent Development
Table 77. Affymetrix Inc.(US) Corporation Information
Table 78. Affymetrix Inc.(US) Description and Business Overview
Table 79. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Affymetrix Inc.(US) Product
Table 81. Affymetrix Inc.(US) Recent Development
Table 82. Johnson & Johnson(US) Corporation Information
Table 83. Johnson & Johnson(US) Description and Business Overview
Table 84. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Johnson & Johnson(US) Product
Table 86. Johnson & Johnson(US) Recent Development
Table 87. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 88. Thermo Fisher Scientific Inc.(US) Description and Business Overview
Table 89. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Thermo Fisher Scientific Inc.(US) Product
Table 91. Thermo Fisher Scientific Inc.(US) Recent Development
Table 92. GE Healthcare(England) Corporation Information
Table 93. GE Healthcare(England) Description and Business Overview
Table 94. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. GE Healthcare(England) Product
Table 96. GE Healthcare(England) Recent Development
Table 97. Life Technologies Corp.(US) Corporation Information
Table 98. Life Technologies Corp.(US) Description and Business Overview
Table 99. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Life Technologies Corp.(US) Product
Table 101. Life Technologies Corp.(US) Recent Development
Table 102. Luminex Corp.(US) Corporation Information
Table 103. Luminex Corp.(US) Description and Business Overview
Table 104. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Luminex Corp.(US) Product
Table 106. Luminex Corp.(US) Recent Development
Table 107. Cepheid Inc.(US) Corporation Information
Table 108. Cepheid Inc.(US) Description and Business Overview
Table 109. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Cepheid Inc.(US) Product
Table 111. Cepheid Inc.(US) Recent Development
Table 112. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 113. Allegro Diagnostics Corp.(Brazil) Description and Business Overview
Table 114. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Allegro Diagnostics Corp.(Brazil) Product
Table 116. Allegro Diagnostics Corp.(Brazil) Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Next Generation Cancer Diagnostic Devices Customers List
Table 120. Next Generation Cancer Diagnostic Devices Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Next Generation Cancer Diagnostic Devices Market Size 2017-2028 (US$ Million)
Figure 4. Global Next Generation Cancer Diagnostic Devices Sales 2017-2028 (K Pcs)
Figure 5. United States Next Generation Cancer Diagnostic Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Next Generation Cancer Diagnostic Devices Market Size 2017-2028 (US$ Million)
Figure 7. United States Next Generation Cancer Diagnostic Devices Sales 2017-2028 (K Pcs)
Figure 8. United States Next Generation Cancer Diagnostic Devices Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Next Generation Cancer Diagnostic Devices Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Next Generation Cancer Diagnostic Devices Report Years Considered
Figure 11. Product Picture of Next Generation Sequencing
Figure 12. Product Picture of qPCR & Multiplexing
Figure 13. Product Picture of Lab-on- a- chip (LOAC)
Figure 14. Product Picture of Protein Microarrays
Figure 15. Product Picture of DNA Microarrays
Figure 16. Product Picture of Reverse Transcriptase-PCR (RT-PCR)
Figure 17. Global Next Generation Cancer Diagnostic Devices Market Share by Type in 2022 & 2028
Figure 18. Global Next Generation Cancer Diagnostic Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Next Generation Cancer Diagnostic Devices Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028) & (K Pcs)
Figure 21. Global Next Generation Cancer Diagnostic Devices Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Next Generation Cancer Diagnostic Devices Price by Type (2017-2028) & (USD/Pcs)
Figure 23. United States Next Generation Cancer Diagnostic Devices Market Share by Type in 2022 & 2028
Figure 24. United States Next Generation Cancer Diagnostic Devices Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Next Generation Cancer Diagnostic Devices Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Next Generation Cancer Diagnostic Devices Sales by Type (2017-2028) & (K Pcs)
Figure 27. United States Next Generation Cancer Diagnostic Devices Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Next Generation Cancer Diagnostic Devices Price by Type (2017-2028) & (USD/Pcs)
Figure 29. Product Picture of Biomarker Development
Figure 30. Product Picture of CTC Analysis
Figure 31. Product Picture of Proteomic Analysis
Figure 32. Product Picture of Epigenetic Analysis
Figure 33. Product Picture of Genetic Analysis
Figure 34. Global Next Generation Cancer Diagnostic Devices Market Share by Application in 2022 & 2028
Figure 35. Global Next Generation Cancer Diagnostic Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. Global Next Generation Cancer Diagnostic Devices Sales Market Share in Value by Application (2017-2028)
Figure 37. Global Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028) & (K Pcs)
Figure 38. Global Next Generation Cancer Diagnostic Devices Sales Market Share in Volume by Application (2017-2028)
Figure 39. Global Next Generation Cancer Diagnostic Devices Price by Application (2017-2028) & (USD/Pcs)
Figure 40. United States Next Generation Cancer Diagnostic Devices Market Share by Application in 2022 & 2028
Figure 41. United States Next Generation Cancer Diagnostic Devices Sales in Value by Application (2017-2028) & (US$ Million)
Figure 42. United States Next Generation Cancer Diagnostic Devices Sales Market Share in Value by Application (2017-2028)
Figure 43. United States Next Generation Cancer Diagnostic Devices Sales by Application (2017-2028) & (K Pcs)
Figure 44. United States Next Generation Cancer Diagnostic Devices Sales Market Share in Volume by Application (2017-2028)
Figure 45. United States Next Generation Cancer Diagnostic Devices Price by Application (2017-2028) & (USD/Pcs)
Figure 46. North America Next Generation Cancer Diagnostic Devices Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 47. North America Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. U.S. Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Canada Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Europe Next Generation Cancer Diagnostic Devices Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 51. Europe Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. Germany Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. France Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.K. Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Italy Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Russia Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 58. Asia-Pacific Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 59. China Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Japan Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. South Korea Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. India Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Australia Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Taiwan Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Indonesia Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Thailand Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Malaysia Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Philippines Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Latin America Next Generation Cancer Diagnostic Devices Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Latin America Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Mexico Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Brazil Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Argentina Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 75. Middle East & Africa Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 76. Turkey Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. U.A.E Next Generation Cancer Diagnostic Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. Next Generation Cancer Diagnostic Devices Value Chain
Figure 80. Next Generation Cancer Diagnostic Devices Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount